Abstract:Background: Docetaxel (DOC) is the main chemotherapeutic agent for the treatment of advanced metastatic prostate cancer. Docetaxel shows anticancer effects by preventing the depolymerization of microtubules in the cell, therefore preventing cell division. However, the low survival effect of docetaxel has prompted researchers to search for novel therapeutic agents. Fucoidan (FUC) is a sulfated polysaccharide derived from brown algae. It has many bioactivities which makes fucoidan a promising anticancer agent. In this study, the potential anti-tumorigenic and preventive effects of fucoidan with or without docetaxel in prostate cancer were investigated by analyzing different cell death modalities. Methods: The in-vivo six groups (n = 8) were conducted; preventive (Pt), docetaxel treated after preventive (Pt-D), control, fucoidan (FUC), docetaxel (DOC), and FUC and DOC (FUC+DOC) combination. Apoptotic, necroptotic, and autophagic cell death-related protein expressions were assessed in tumor tissues by using immunohistochemical staining. Oxidative stress-related lipid peroxidation, glutathione peroxidase, and glutathione levels were also determined in tumor tissues. Results: Although apoptotic, necroptotic, and autophagic cell deaths were significantly induced in agent-treated groups compared to the control. Apoptotic cell death was more significantly induced in FUC and FUC+DOC-treated groups. Necroptotic cell death was increased considerably by inducing MLKL protein expression in all treatment groups. In the FUC, Pt, and DOC groups, LC3A/B expressions were significantly increased. DOC, FUC+DOC, and Pt-D treatments caused a significant increase in Beclin-1 expression. Oxidative stress-related MDA, GPX, and GSH levels significantly decreased with FUC treatment. The anti-tumorigenic effects of FUC and DOC were also demonstrated through tumor size reduction. Conclusion: According to the findings of this study, FUC inhibited tumor growth temporally and dimensionally, especially in preventive applications. FUC and FUC+DOC combinations in both treatment groups showed anti-tumorigenic effects. The results of this study suggest that fucoidan is a promising anticancer agent against prostate cancer. FUC can be considered as a preventive or treatment agent in prostate cancer therapy with DOC. Further studies are needed to fully elucidate the mechanism of action of fucoidan in metastatic prostate cancer.

Proliferative effects of fucoidan on neural cells

Comparison of proliferative effects of Fucoidan, Shuxuening injection and Danhong injection on neural cells

Fucoidan Induces G1 Phase Arrest and Apoptosis Through Caspases-Dependent Pathway and ROS Induction in Human Breast Cancer MCF-7 Cells.

Effects of Fucoidan on cell viability of breast cancer and its mechanism

[Effects of fucoidan inducing impairment of human osteosarcoma cell 143B and its mechanism]

Fucoidan Induces Apoptosis of Hepg2 Cells by Down-Regulating P-Stat3

Brown Algae-Derived Fucoidan Exerts Oxidative Stress-Dependent Antiproliferation on Oral Cancer Cells

Fucoidan ameliorates amyloid-β 42 oligomer-induced neuronal apoptosis by activating the PI3K/Akt signaling pathway and MAPK cascades in human neuroblastoma SH-SY5Y cells

Fucoidan Suppresses Mitochondrial Dysfunction and Cell Death against 1-Methyl-4-Phenylpyridinum-Induced Neuronal Cytotoxicity via Regulation of PGC-1α Expression

The Protective Effect of Stichopus japonicus Fucoidan on PC12 Cells with Hypoxia/Reoxygenation Injury

The Natural Product Fucoidan Inhibits Proliferation and Induces Apoptosis of Human Ovarian Cancer Cells: Focus on the PI3K/Akt Signaling Pathway

Fucoidan Inhibits Prostate Cancer Growth Through Modulation of Different Cell Deaths

Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo

Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways

Fucoidan affects oral squamous cell carcinoma cell functions <i>in vitro</i> by regulating FLNA-derived circular RNA

Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury

In vitro and in vivo immunomodulatory effects of fucoidan compound agents

Fucoidan Inhibits Proliferation of the SKM-1 Acute Myeloid Leukaemia Cell Line Via the Activation of Apoptotic Pathways and Production of Reactive Oxygen Species.

Investigation Of Different Molecular Weight Fucoidan Fractions Derived From New Zealand Undaria Pinnatifida In Combination With Groa Therapy In Prostate Cancer Cell Lines

Fucoidan present in brown algae induces apoptosis of human colon cancer cells